IHS馬基特 INFO 深 滬
等待開盤 12-12 09:30:00 美东时间
24.7081
+0.052
+0.21%
華盛通- 最 高24.72
- 今 開24.58
- 成交量 3375股
- 最 低 24.58
- 昨 收 24.656
- 總市值 8709.61万
- 52周最高 24.72
- 市盈率 靜 8.22
- 換手率 0.10%
- 52周最低 17.15
- 委 比 0.00%
- 總股本 352.50万
- 歷史最高 24.72
- 量 比 0.54
- 振 幅 0.57%
- 歷史最低 17.15
- 每 手 1
- 風險率 1.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK Ab+ gMG THOUSAND OAKS, C...
今天 07:09
Cycle Pharmaceuticals to Acquire Applied Therapeutics
Applied Therapeutics, a biopharmaceutical company developing treatments for rare diseases, announced that Cycle Group Holdings will acquire the company. Cycle will offer $0.088 per share plus contingent value rights (CVRs) tied to regulatory approvals and sales milestones. The transaction, expected to close in early 2026, was approved by Applied’s board after evaluating strategic options. Applied’s lead drug, govorestat, targets rare CNS metaboli...
12-11 22:25
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
<p>Telix Pharmaceuticals and Varian, a Siemens Healthineers company, announce a strategic clinical collaboration to develop novel applications combining Telix's theranostic products with external beam radiation therapy (EBRT) for enhanced cancer treatment. The partnership focuses on PSMA-PET imaging for prostate cancer patients, utilizing Telix's Gozellix® and Illuccix® to improve patient selection, personalized treatment plans, and response moni...
12-10 12:00
Strive Announces $500,000,000 SATA At-The-Market Program
Strive, Inc. announced a $500 million ATM program to issue and sell shares of its Variable Rate Series A Perpetual Preferred Stock (SATA Stock). Proceeds will be used for general corporate purposes, including Bitcoin acquisition, working capital, capital expenditures, share buybacks, debt repayment, and potential business acquisitions. The company currently holds approximately 7,525 bitcoins and manages over $2 billion in assets.
12-09 23:27
Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor
CAMBRIDGE, Mass., Dec. 9, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that industry pioneer Zooko Wilcox, the founder of Zcash, former CEO of the Electri...
12-09 20:00
Alexander & Baldwin to be Taken Private in $2.3 Billion Transaction
Shareholders to Receive $21.20 Per Share in Cash Representing a 40.0% Premium to Closing Price on December 8, 2025 HONOLULU, Dec. 8, 2025 /PRNewswire/ -- Alexander & Baldwin, Inc., (NYSE: AL...
12-09 06:30
Warner Bros. Discovery Confirms Receipt of Paramount Skydance Unsolicited Tender Offer
NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Warner Bros. Discovery, Inc. ("Warner Bros. Discovery" or "WBD") (NASDAQ: WBD) today confirmed Paramount Skydance Corporation ("Paramount Skydance") (N...
12-09 02:22
Carver Bancorp, Inc. Commences Trading on OTC Markets
Stockholders can access price quotes and volume data at www.OTCmarkets.com and on other public platforms Transition paves the way for increased flexibility to improve operational excellence,...
12-08 21:00
Xanadu Expands Partnership with A*STAR to Advance Photonic Quantum Computing
Quantum computing company Xanadu signed a Memorandum of Understanding with Singapore's A*STAR to expand its research collaboration, aiming to advance quantum technologies and establish joint labs in Singapore. The agreement builds on Xanadu's existing partnership with A*STAR's Institute of Microelectronics, now including the Institute of High Performance Computing and Quantum Innovation Centre. Xanadu and A*STAR will collaborate on projects like ...
12-08 14:00
Announcement relating to despatch of Rule 15 proposal
Avadel Pharmaceuticals and Alkermes have reached an agreement for Alkermes to acquire Avadel through a scheme of arrangement under Irish law. The transaction involves notifying equity award holders and ESPP participants, with detailed proposals available on both companies' websites. Shareholders are advised to review the Definitive Proxy Statement and related documents before making any voting decisions. The offer period began on October 22, 2025...
12-05 21:01
